Cytokines and implantation

Chemical Immunology and Allergy

Volumn 88, Issue , 2005, Pages 34-63

  Chaouat, Gérard ^a,b   Ledée Bataille, Nathalie ^a   Chea, Karen Bonnet ^a   Dubanchet, Sylvie ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; COLONY STIMULATING FACTOR 1; CYTOKINE; EARLY PREGNANCY FACTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6; TAU INTERFERON; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

AUTOIMMUNITY; BLASTOCYST; CELL ACTIVATION; CORPUS LUTEUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE STERILITY; HUMAN; MONOCYTE; NIDATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH2 CELL; TH3 CELL; TROPHOBLAST; UTERUS; VASCULARIZATION;

ANIMALS; CORPUS LUTEUM; CYTOKINES; EMBRYO; EMBRYO IMPLANTATION; FEMALE; HUMANS; UTERUS;

EID: 30844440998     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000087820     Document Type: Review

References (278)

1. Wegmann TG: Fetal protection against abortion: Is it immuno suppression or immunostimulation? Ann Immunol Inst Pasteur 1984;135D:309-311.
2. Athanassakis I, Bleackley RC, Paetkau V, Guibert LL, Barrp J, Wegmann TG: The immunostimulatory effects of T cells and T cell lymphokines on murine fetally derived placental cells. J Immunol 1987;138:37-44.
3. Armstrong DT, Chaouat G: Effects of lymphokines and immune complexes on murine placental cell growth in vitro. Biol Reprod 1989;40:466-475.
4. Chaouat G, Menu E, DY M, Minkowski M,Clark DA, Wegmann TG: Control of fetal survival in CBA X DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990;89:447-458.
5. Bartocci A, Pollard JW, Stanley ER: Regulation of colony stimulating factor 1 during pregnancy. J Exp Med 1986;164:956-961.
6. Pollard JW, Hunt JW, Wiktor-Jedrzejczak W, Stanley ER: A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol 1991;148:273-283.
7. Cohen PE, Chisholm O, Arceci RJ, Stanley ER, Pollard JW: Absence of CSF1 in osteopetrotic (csfmop/csfmop) mice results in male fertility defects. Biol Reprod 1996;55:310-317.
8. Thibault C: Reproduction in Mammals and Man. Paris, Ellipses, 1993, pp 461-475
9. Edwards RG: Implantation, interception and contraception. Hum Reprod 1994;9:985-995.
10. Loke YW, King A: Human Implantation. Cell Biology and Immunology. London, Cambridge University Press, 1995.
11. Croy BA, Chantakru S, Esadeg S, Ashkar AA, Wei Q: Decidual natural killer cells: Key regulators of placental development (a review). J Reprod Immunol 2002;57/1-2:151-168.
12. Proll J, Bensussan A, Goffin F, Foidart JM, Berrebi A, Le Bouteiller P: Tubal versus uterine placentation: Similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment. Tissue Antigens 2000;56:479-491.
13. Daniel Y, Geva E, Lerner-Geva L, Eshed-Englender T, Gamzu R, Lessing JB, Bar-Am A, Amit A: Levels of vascular endothelial growth factor are elevated in patients with ectopic pregnancy: Is this a novel marker? Fertil Steril 1999;72:1013-1017.
14. Felemban A, Sammour A, Tulandi T: Serum vascular endothelial growth factor as a possible marker for early ectopic pregnancy. Hum Reprod 2002;17:490-492.
15. Kucera-Sliutz E, Schiebel I, Konig F, Leodolter S, Sliutz G, Koelbl H: Vascular endothelial growth factor (VEGF) and discrimination between abnormal intrauterine and ectopic pregnancy. Hum Reprod 2002;17:3231-3234.
16. Wegner NT, Mershon JL: Evaluation of leukemia inhibitory factor as a marker of ectopic pregnancy. Am J Obstet Gynecol 2001;184:1074-1076.
17. McMinn MJ, Hines RS, Walley RB, Cowan BD: Leukemia inhibitory factor and homeobox a10 gene expression in an ectopic pregnancy model for implantation. Am J Obstet Gynecol 2004; 190:1419-1421.
18. Soriano D, Hugol D, Quang NT, Darai E: Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy. Fertil Steril 2003;79:975-980.
19. Mulayim N, Palter SF, Selam B, Arici A: Expression and regulation of interleukin-8 in human fallopian tubal cells. Am J Obstet Gynecol 2003;188:651-656.
20. Morton H, Hegh V, Clunie GJA: Immunosuppression detected in pregnant mice by the rosette inhibition test. Nature 1974;249:459-460
21. Morton H, Rolfe B, Clunie GJA, et al: An early pregnancy factor detected in human serum by the rosette inhibition test. Lancet 1977;i:394-397.
22. Morton H, Nancarrow CD, Scaramuzzi RJ, et al: Detection of early pregnancy in sheep by rosette inhibition test. J Reprod Fertil 1979;56:75-80.
23. Cavanagh AC, Morton H: The purification of early-pregnancy factor to homogeneity from human platelets and identification as chaperonin 10. Eur J Biochem 1994;222:551-560.
24. Orozco C, Clark IQ, Cock IE, Clarke FM: A description of the basic system of components in pregnant mice sera responsible for 'early pregnancy factor' activity. J Reprod Fertil 1994;100/1:291-297.
25. Clark IQ, Orozco C, Cock IE, Clarke FM: The 'early pregnancy factor' revisited; the effect of ammonium sulfate on the capacity of pregnant mouse sera to express activity in the rosette inhibition assay. J Reprod Fertil 1994;100:279-289.
26. Clarke FM: Identification of molecules and mechanisms involved in the 'early pregnancy factor' system. Reprod Fertil Dev 1992;4:423-433.
27. Morton H, Cavanagh AC, Athanasas-Platsis S, Quinn KA, Rolfe BE: Early pregnancy factor has immunosuppressive and growth factor properties. Reprod Fertil Dev 1992;4:411-422.
28. Clarke FM, Orozco C, Perkins AV, Cock I, Tonissen KF, Robins AJ, Wells JR: Identification of molecules involved in the 'early pregnancy factor' phenomenon. J Reprod Fertil 1991;93:525-539.
29. Clarke FM: Controversies in assisted reproduction and genetics. Does 'EPF' have an identity? J Assist Reprod Genet 1997;14:489-491.
30. Aranha C, Bordekar A, Shahani S: Isolation and purification of an early pregnancy factor-like molecule from culture supernatants obtained from lymphocytes of pregnant women. I. Identification of the molecule as a Fc-receptor-like molecule: A preliminary report. J Assist Reprod Genet 1998;15:619-624.
31. Zhang B, Walsh MD, Nguyen KB, Hillyard NC, Cavanagh AC, McCombe PA, Morton H: Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitro chloro benzene in normal BALB/c mice. J Neurol Sci 2003;212/1-2:37-46.
32. Athanasas-Platsis S, Zhang B, Hillyard NC, Cavanagh AC, Csurhes PA, Morton H, McCombe PA: Early pregnancy factor suppresses the infiltration of lymphocytes and macrophages in the spinal cord of rats during experimental autoimmune encephalomyelitis but has no effect on apoptosis. J Neurol Sci 2003;214/1-2:27-36.
33. Mayumi T, Bitoh S, Anan S, Hama T, Fujimoto S, Yamamoto H: Suppressor T lymphocyte induction by a factor released from cultured blastocysts. J Immunol 1985;134:404-408.
34. Daya S, Clark DA: Immunosuppressive factor (or factors) produced by human embryo in vitro. N Engl J Med 1986;315:1551-1552.
35. Armstrong DT, Chaouat G, Guichard A, Cedard L, Andreu G, Denver L: Lack of correlation of immunosuppressive activity secreted by human in vitro fertilized (IVF) ova with successful pregnancy. J In Vitro Fert Embryo Transf 1989;6/1:15-21.
36. Roussev RG, Coulam CB, Kaider BD, Yarkoni M, Leavis PC, Barnea ER: Embryonic origin of preimplantation factor (PIF): Biological activity and partial characterization. Mol Hum Reprod 1996;2:883-887.
37. Coulam CB, Roussev RG, Thomason EJ, Barnea ER: Preimplantation factor (PIF) predicts subsequent pregnancy loss. Am J Reprod Immunol 1995;34/2:88-92.
38. Sharkey AM, Dellow K, Blayney M, Macnamee M, Charnock-Jones S, Smith SK: Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos. Biol Reprod 1995;53:974-981.
39. Orvieto R, Bar-Hava I, Schwartz A, Shelef M, Ben-Rafael Z: Interleukin-2 production by human pre-implantation embryos. Gynecol Endocrinol 1997;11:331-334.
40. Krussel JS, Simon C, Rubio MC, Pape AR, Wen Y, Huang HY, Bielfeld P, Polan ML: Expression of interleukin-1 system mRNA in single blastomeres from human preimplantation embryos. Hum Reprod 1998;13:2206-2211.
41. Basak S, Dubanchet S, Zourbas S, Chaouat G, Das C: Expression of pro-inflammatory cytokines in mouse blastocysts during implantation: Modulation by steroid hormones. Am J Reprod Immunol 2002;47/1:2-11.
42. Fasouliotis SJ, Spandorfer SD, Witkin SS, Schattman G, Liu HC, Roberts JE, Rosenwaks Z: Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies. Hum Reprod 2004;19:1357-1363.
43. Spandorfer SD, Neuer A, Liu HC, Rosenwaks Z, Witkin SS: Involvement of interleukin-1 and the interleukin-1 receptor antagonist in in vitro embryo development among women undergoing in vitro fertilization-embryo transfer. J Assist Reprod Genet 2003;20:502-505.
44. Spandorfer SD, Neuer A, Liu HC, Bivis L, Clarke R, Veeck L, Witkin SS, Rosenwaks Z: Interleukin-1 levels in the supernatant of conditioned media of embryos grown in autologous endometrial coculture: Correlation with outcome after in vitro fertilization. Am J Reprod Immunol 2000;43/1:6-11.
45. Austgulen R, Arntzen KJ, Vatten LJ, Kahn J, Sunde A: Detection of cytokines (interleukin-1, interleukin-6, transforming growth factor-beta) and soluble tumour necrosis factor receptors in embryo culture fluids during in-vitro fertilization. Hum Reprod 1995;10:171-176.
46. Baranao RI, Piazza A, Rumi LS, Polak de Fried E: Determination of IL-1 and IL-6 levels in human embryo culture-conditioned media. Am J Reprod Immunol 1997;37:191-194.
47. Ines Baranao R, Piazza A, Rumi LS, Polak de Fried E: Interleukin-1 beta levels in human embryo culture supernatants and their predictive value for pregnancy. Early Hum Dev 1997;48/1-2:71-80.
48. Spandorfer SD, Navarro J, Levy D, Black AR, Liu HC, Veeck L, Witkin SS, Rosenwaks Z: Autologous endometrial coculture in patients with in vitro-fertilization (IVF) failure: Correlations of outcome with leukemia inhibiting factor (LIF) production. Am J Reprod Immunol 2001;46:375-380.
49. Desai NN, Goldfarb JM: Growth factor/cytokine secretion by a permanent human endometrial cell line with embryotrophic properties. J Assist Reprod Genet 1996;13:546-550.
50. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucci A, Baricordi OR: HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002;32:311-315.
51. Sher G, Keskintepe L, Nouriani M, Roussev R, Batzofin J: Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of 'embryo competency' and IVF outcome. Reprod Biomed Online 2004;9:74-78.
52. Allen WR, Kydd JH, Antzack DF: Successful application of immunotherapy to a model of pregnancy failure in equids; in Clark DA, Croy BA (eds): Reproductive Immunology. Amsterdam, Elsevier,1986, pp 253-261.
53. Charpigny G, Reinaud P, Huet JC, Guillomot M, Charlier M, Pernollet JC, Martal J: High homology between a trophoblastic protein (trophoblastin) isolated from ovine embryos and alpha interferon. FEBS Lett 1988;228:12-16.
54. Charlier M, Hue D, Martal J, Gayle P: Cloning and expression of cDNA encoding ovine trophoblastin. Its identity with class II interferons. Gene 1989;77:341-348.
55. Martal J, Chêne N, Huynh L, L'Haridon R, Reinaud P, Guillomot M, Charlier M, Charpigny G: IFN-tau: A novel subtype I IFN. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie 1998;80:755-777.
56. Martal J: Immunological and biological properties of oTP1 trophoblastin; in Chaouat G, Mowbray J (eds): Cellular and Molecular Biology of the Fetomaternal Interface. Colloques INSERM. Paris, INSERM/John Libbey Eurotexte, 1991.
57. Bazer FW, Spencer TE, Ott TL: Interferon tau: A novel pregnancy recognition signal. Am J Reprod Immunol 1997;37:412-421.
58. Martal J,Chêne N, Camous S, Huynh L, Lantier F, Hermier P, l'Haridon R, Charpigny G, Charlier M, Chaouat G: Recent developments and potentialities for reducing embryo mortality in ruminants: The role of IFN-τ and other cytokines in early pregnancy. Reprod Fertil Dev 1997;9:355-380.
59. Roberts RM, Ezashi T, Rosenfeld CS, Ealy AD, Kubisch HM: Evolution of the interferon tau genes and their promoters, and maternal-trophoblast interactions in control of their expression. Reprod Suppl 2003;61:239-251.
60. Fillion C, Chaouat G,Reinaud P, Charpigny JC, Martal J: Immunoregulatory effects of trophoblastin (oTP): All 5 isoforms are immunosuppressive of PHA driven lymphocyte proliferation. J Reprod Immunol 1991;19/3:237-249.
61. Assal-Meliani A, Charpigny G, Reinaud P, Martal J, Chaouat G: Recombinant ovine trophoblastin (roTP) inhibits ovine, murine and human lymphocyte proliferation. J Reprod Immunol 1993;25:148-165.
62. Tekin S, Ealy AD, Wang SZ, Hansen PJ: Differences in lymphocyte- regulatory activity among variants of ovine IFN-tau. J Interferon Cytokine Res 2000;20:1001-1005.
63. Assal Meliani A, Kinsky R, Martal J, Chaouat G: In vivo effects of recombinant ovine interferon-tau (trophoblastin): r.oTP prevents local GVH reaction in mice (PLN assay), prevents resorptions and favours implantation in the CBA/J X DBA/2 mating combination. Am J Reprod Immunol 1995;33:267-275.
64. Chaouat G, Assal Meliani A, Martal J, Raghupathy R, John Elliot, Mossmann T, Wegmann TG: Il-10 prevents inflammatory cytokine-mediated foetal death and is inducible by tau interferon. J Immunol 1995;152:2411-2420.
65. Mujtaba MG, Villarete L, Johnson HM: IFN-tau inhibits IgE production in a murine model of allergy and in an IgE-producing human myeloma cell line. J Allergy Clin Immunol 1999;104:1037-1044.
66. Soos JM, Stuve O, Youssef S, Bravo M, Johnson HM, Weiner HL, Zamvil SS: Cutting edge: Oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate. J Immunol 2002;169:2231-2235.
67. Juste RA, Ott TL, Kwang J, Bazer FW, de la Concha-Bermejillo A: Effects of recombinant ovine interferon-tau on ovine lentivirus replication and progression of disease. J Gen Virol 2000;81:525-532.
68. Rogez C, Martin M, Dereuddre-Bosquet N, Martal J, Dormont D, Clayette P: Anti-human immunodeficiency virus activity of tau interferon in human macrophages: Involvement of cellular factors and beta-chemokines. J Virol 2003;77:12914-12920.
69. Nagaoka K, Sakai A, Nojima H, Suda Y, Yokomizo Y, Imakawa K, Sakai S, Christenson RK: A chemokine, interferon (IFN)-gamma-inducible protein 10 kDa, is stimulated by IFN-tau and recruits immune cells in the ovine endometrium. Biol Reprod 2003r;68:1413-1421.
70. Choi Y, Johnson GA, Spencer TE, Bazer FW: Pregnancy and interferon tau regulate major histocompatibility complex class I and beta2-microglobulin expression in the ovine uterus. Biol Reprod 2003;68:1703-1710.
71. Emond V, MacLaren LA, Kimmins S, Arosh JA, Fortier MA, Lambert RD: Expression of cyclooxygenase-2 and granulocyte-macrophage colony-stimulating factor in the endometrial epithelium of the cow is up-regulated during early pregnancy and in response to intrauterine infusions of interferon-tau. Biol Reprod 2004;70/1:54-64.
72. Wang B, Goff AK: Interferon-tau stimulates secretion of macrophage migration inhibitory factor from bovine endometrial epithelial cells. Biol Reprod 2003;69:1690-1696.
73. Stewart DM, Johnson GA, Vyhlidal CA, Burghardt RC, Safe SH, Yu-Lee LY, Bazer FW, Spencer TE: Interferon-tau activates multiple signal transducer and activator of transcription proteins and has complex effects on interferon-responsive gene transcription in ovine endometrial epithelial cells. Endocrinology 2001;142/1:98-107.
74. Takahashi M, Takahashi H, Hamano S, Watanabe S, Inumaru S, Geshi M, Okuda K, Yokomizo Y, Okano A: Possible role of interferon-tau on in vitro development of bovine embryos. J Reprod Dev 2003;49/4:297-305.
75. Lonergan P, Rizos D, Gutierrez-Adan A, Moreira PM, Pintado B, de la Fuente J, Boland MP: Temporal divergence in the pattern of messenger RNA expression in bovine embryos cultured from the zygote to blastocyst stage in vitro or in vivo. Biol Reprod 2003;69:1424-1431.
76. Nagaoka K, Nojima H, Watanabe F, Chang KT, Christenson RK, Sakai S, Imakawa K: Regulation of blastocyst migration, apposition, and initial adhesion by a chemokine, interferon gamma-inducible protein 10 kDa (IP-10), during early gestation. J Biol Chem 2003;278:29048-29056.
77. Stewart MD, Choi Y, Johnson GA, Yu-Lee LY, Bazer FW, Spencer TE: Roles of Stat1, Stat2, and interferon regulatory factor-9 (IRF-9) in interferon tau regulation of IRF-1. Biol Reprod 2002;66:393-400.
78. Rosenfeld CS, Han CS, Alexenko AP, Spencer TE, Roberts RM: Expression of interferon receptor subunits, IFNAR1 and IFNAR2, in the ovine uterus. Biol Reprod 2002;67:847-853.
79. Ezashi T, Roberts RM: Interaction of SAPK interacting protein-1 (Sin1) with the interferon receptor sub-unit IFNAR2 in uterine endometrium. In press.
80. Chard T, Craig PH, Menabawey L, Lee C: Alpha interferon in human pregnancy. Br J Obstet Gynaecol 1986;93:1145-1149.
81. Whaley AE, Reddy Meka CS, Harbison LA, Hunt JS, Imakawa K: Identification and cellular localisation of unique interferon mRNA from human placenta. J Biol Chem 1994;269:10864-10868.
82. Zidovec Lepej S, Vujisic S, Stipoljev F, Mazuran R: Interferon-alpha-like biological activity in human seminal plasma, follicular fluid, embryo culture medium, amniotic fluid and fetal blood. Reprod Fertil Dev 2004;15:423-428.
83. Medawar PB: Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953;7:320-338.
84. Wegmann TG, Lin H, Guilbert L, Mossman TH: Bidirectional cytokines interactions in the materno fetal relationship: Successful allopregnancy is a Th2 phenomenon. Immunol Today 1993;14:353-355.
85. Fondation Mérieux: Early Embryo Development, Uterus Preparation and Role of Cytokines in Implantation and Labour. Editions Mérieux, Lyon, 1995.
86. Noun A, Acker G, Chaouat G, Antoine JC, and Garabedian M: Macrophages and T lymphocyte bearing antigens bearing cells in the uterus before and during ovum implantation in the rat. Clin Exp Immunol 1989;78:434-438.
87. Kachkache M, Acker GM, Chaouat G, Noun A, Garabedian: Hormonal and local factors control the immunohistochemical distribution of immunocytes in the rat uterus before conceptus implantation: Effects of ovariectomy, fallopian tube section and RU 486 injection. Biol Reprod 1991;45:860-865.
88. Sanford TR, De M, Wood G: Expression of colony stimulating factors and inflammatory cytokines in the uterus if CD1 mice during days 1 to days 3 of pregnancy. J Reprod Fertil 1992;94:213-220.
89. McMaster MT, Newton RC, Sudhanski K, Dey SK, Andrews GK: Activation and distribution of inflammatory cells in the mouse uterus during the preimplantation period. J Immunol 1992;148:1699-1705.
90. Daiter E, Pampfer S, Yeung YG, Barad D, Stanley ER, Pollard JW: Expression of colony-stimulating factor-1 in the human uterus and placenta. J Clin Endocrinol Metab 1992;74:850-858.
91. Arceci B, Shanahan F, Stanley ER, Pollard JW: The temporal expression and localisation of colony stimulating factor (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1 regulated placental development. Proc Natl Acad Sci USA 1989;86:8811-8818.
92. Azuma C, Saji F, Kimura T, Tokugawa Y, Takemira M, Samejima Y, Tanizawa O: Steroid hormones induce macrophage colony-stimulating factor (M-CSF) and M-CSF receptor mRNAs in the human endometrium. J Mol Endocrinol 1990;5:103-108.
93. Kariaya M, Kanzaki H, Hanamura T, Imai K, Narukawa S, Inoue T, Hatayama H, Mori T: Progesterone-dependent secretion of macrophage colony-stimulating factor by human endometrial stromal cells of non-pregnant uterus in culture. J Clin Endocrinol Metab 1994;79:86-90.
94. Tartakowsky B, Gorelik E: Murine models of immunologically induced abortions, in Chaouat G (ed): Colloque INSERM CNRS Immunologie de la relation foeto-maternelle. Paris, INSERM, vol 154, pp 399-412.
95. Tartakowsky B, Goldstein O, Ben Yair B: In vivo modulation of preembryonic development by cytokines; in Biologie cellulaire et moléculaire de la relation materno-fetale. Paris, INSERM John Libbey, 1991, pp 239-245.
96. Simon C, Frances A, Piquette GN el Danasouri I, Zurawski G, Dang W, Polan ML: Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 1994;134:521-528.
97. Parand M, Chedid L: Protective effects of chlorpromazine against endotoxin induced abortion. Proc Soc Exp Biol Med 1964;116:906-915.
98. Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA: Cytokine dependent abortion in CBA X DBA/2 mice is mediated by the procoagulant fgl/2 prothrombinase. J Immunol 1998;160:550-555.
99. Chaouat G, Kiger N, Wegmann TG: Vaccination against spontaneous abortion in mice. J Reprod Immunol 1983;8:389-394.
100. Hamilton MS, Hamilton BL: Environmental influences on immunologically associated recurrent spontaneous abortion in CBA/J mice. J Reprod Immunol 1987;11:237-241.
101. Simon C, Piquette GN, Frances A, Polan ML: Localisation of interleukin 1 type 12 receptor and interleukin 1beta in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab 1993;77:594-595.
102. Simon C, Frances A, Piquette GN, Zurawsky G, Deng W, Polan ML: Inter-leukin 1 system in the materno trophoblast unit in human implantation. Immunohistochemical evidence for autocrine/paracrine function. J Clin Endocrinol Metab 1994;878:847-854.
103. De Los Santos MJ, Mercader A, Frances A, Portoles E, Remohi J, Pellicer A, Simon C: Role of endometrial factors in regulating secretion of components of the human embryonic interleukin 1 system during embryonic development. Biol Reprod 1996;54:563-574.
104. Simon C, Mercader A, Gimeno MJ, Pellicer A: The interleukin 1 system and human implantation. Am J Reprod Immunol 1997;37/1:64-72.
105. Kauma S, Matt D, Strom S, Eirman D, Tuner T: Interleukin 1 beta (IL-1 beta), human leucocyte antigen HLA-DR alpha, and transforming growth factor beta (TGF beta) expression in endometrium, placenta and placental membranes. Am J Obstet Gynecol 1990;163:1430-1437.
106. Frank GR, Brar AK, Jirihara H, Cedars MI, Handweger S: Interleukin 1 beta and endometrium: An inhibitor of stromal cell differentiation and possible autoregulator of decidualisation in human. Biol Reprod 1995;52:184-191.
107. Steelee GL, Currie WD, Leung E, Yuen BH, Leung PCK: Rapid stimulation of human chorionic gonadotrophin secretion by interleukin 1 beta from perfused first trimester trophoblast. J Clin Endocrinol Metabol 1992;75:783-788.
108. Editorial: Could there be life without LIF? Nature 1992;359:68.
109. Bhatt H, Brunet LJ, Stewart CL: Uterine expression of leukemia inhibitory factor coincides with the onset of the blastocyst implantation. Proc Natl Acad Sci USA 1991;88:11408-11412.
110. Stewart C, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Köntgen F, Abbondanzo S: Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 1992;359:76-79.
111. Conquet F, Peyrieras N, Tiret L, Brûlet P: Inhibited gastrulation in mouse embryos overexpressing the leukemia inhibitory factor. Proc Natl Acad Sci USA 1992;89:8195-8199.
112. Charnock-Jones DS, Sharkey A, Fenwick P, Smith SK: Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil 1994;101:421-426.
113. Cullinan EB, Abbondazo SJ, PS, Pollard JW, Lessey BA, Stewart CL: Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggest a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci USA 1996;3:3115-3120.
114. Delage G, Moreau J-F, Taupin J-L, Freitas S, Hambartsoumian E, Olivennes F, Fanchin R, Letut-Körnish H, Fydman R, Chaouat G: In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. Hum Reprod 1995;10:2483-2488.
115. Delage G, Moreau J-F, Taupin J-L, Hambartsoumian E, Frydman R, Tartakowsky B, Chaouat G: Abnormal endometrial reactivity to colony stimulating factor 1 and leukemia inhibitory factor dependent female infertility. Contracept Fertil Sex 1997;25:711.
116. Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, Lil TC, Zhang X: The production of leukemia inhibitory factor by human endometrium: Presence in uterine flushings and production by cells in culture. Hum Reprod 1997;12:569-574.
117. Hambartsoumian E: Human endometrial leukemia inhibitor factor (LIF) secretion and its relationship to sonographic endometrial appearance. Am J Reprod Immunol 1997;37:320-325.
118. Arici A, Engin O, Attar E, Olive D: Modulation of leukaemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 1995;80:1908-1915.
119. Giess R, Tanasescu I, Steck T, Sendtner M: Leukaemia inhibitory factor gene mutations in infertile women. Mol Hum Reprod 1999;6:581-586.
120. Steck T, Giess R, Suetterlin MW, Bolland M, Wiest S, Poehls UG, Dietl J: Leukaemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer. Eur J Obstet Gynecol Reprod Biol 2004;112/1:69-73.
121. Taupin JL, Gualde N, Moreau JF: A monoclonal antibody based ELISA for quantitation of human leukaemia inhibitory factor. Cytokine 1997;9:112-118.
122. Haines BP, Voyle RB, Pelton TA, Forrest R, Rathjen PD: Complex conserved organization of the mammalian leukemia inhibitory factor gene: Regulated expression of intracellular and extracellular cytokines. J Immunol 1999;162:4637-4646.
123. Voyle R B, Haines BP, Pera MF, Forrest R, Rathjen PD: Human germ cell tumour cell lines express novel leukaemia inhibitory factor transcripts encoding differentially localised proteins. Exp Cell Res 1999;249/2:199-211.
124. Ledée Bataille N, Lapprée Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G: Concentration of leukemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod 2001;16:2073-2078.
125. Nagaeva O, Jonsson L, Mincheva-Nilsson L: Dominant IL-10 and TGF-beta mRNA expression in gamma delta T cells of human early pregnancy decidua suggests immunoregulatory potential. Am J Reprod Immunol 2002;48/1:9-17.
126. Chaouat G, Cayol V, Mairowitz V, Dubanchet S: Localisation of the Th2 cytokines IL-3, IL-4, IL-10 at the foeto-maternal interface during human and murine pregnancy. Am J Reprod Immunol 1999;42/1:1-14.
127. Chaouat G, Cayol V, Mairowitz V, Dubanchet S: Localisation of the Th2 cytokines IL-3, IL-4, IL-10 at the foeto-maternal interface during human and murine pregnancy and lack of requirement for Fas/Fasl interaction for a successful allogeneic pregnancy; in Gupta SK (ed): Reproductive Immunology. New Delhi, Narosa, 1999, pp 61-71.
128. Roth I, Corry DB, Locksley RM, Anrams JS, Litton MJ, Fisher SJ: Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996;184:539-548.
129. Jurisicova A, Ben-Chetrit A, Varmuza SL, Casper RF: Recombinant human leukemia inhibitory factor does not enhance in vitro human blastocyst formation. Fertil Steril 1995;64:999-1002.
130. Van Eijk MJ, Mandelbaum J, Salat-Baroux J, et al: Expression of leukaemia inhibitory factor receptor subunits LIFR beta and gp130 in human oocytes and preimplantation embryos. Mol Hum Reprod 1996;2:355-360.
131. Chen HF, Shew JY, Ho HN, Hsu WL, Yang YS: Expression of leukemia inhibitory factor and its receptor in preimplantation embryos. Fertil Steril 1999;72:713-719.
132. Dunglison GF, Barlow DH, Sargent IL: Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium. Hum Reprod 1996;11:191-196.
133. Fry RC, Batt PA, Fairclough RJ, Parr RA: Human leukemia inhibitory factor improves the viability of cultured ovine embryos. Biol Reprod 1992;46:470-474.
134. Mitchell MH, Swanson R, Hodgen GD, Oehninger S: Enhancement of in vitro murine embryo development by recombinant leukaemia inhibitory factor. J Soc Gynecol Investig 1994;1:215-219.
135. Kauma SW, Matt DW: Co-culture cells that express leukemia inhibitory factor (LIF) enhance mouse blastocyst development in vitro. J Assist Reprod Genet 1995;12:153-156.
136. Lavranos TC, Rathjen PD, Seamark RF: Trophic effects of myeloid leukaemia inhibitory factor (LIF) on mouse embryos. J Reprod Fertil 1995;105:331-338.
137. Tsai HD, Chang CC, Hsieh YY, Lo HY, Hsu LW, Chang SC: Recombinant human leukemia inhibitory factor enhances the development of preimplantation mouse embryo in vitro. Fertil Steril 1999;71:722-725.
138. Cheung LP, Leung HY, Bongso A: Effect of supplementation of leukemia inhibitory factor and epidermal growth factor on murine embryonic development in vitro, implantation, and outcome of offspring. Fertil Steril 2003;80(suppl 2):727-735.
139. Oshima K, Watanabe H, Yoshihara K, Kojima T, Dochi O, Takenouchi N, Fukushima M, Komatsu M: Gene expression of leukemia inhibitory factor (LIF) and macrophage colony stimulating factor (M-CSF) in bovine endometrium during early pregnancy. Theriogenology 2003;60:1217-1226.
140. Nakajima S, Tanaka T, Umesaki N, Ishiko O: Leukemia inhibitory factor regulates cell survival of normal human endometrial stromal cells. Int J Mol Med 2003;11:353-356.
141. Burrows TD, King A, Loke YW: expression of integrins by human trophoblasts and differential adhesion to laminin and fibronectin. Hum Reprod 1993;8:475-484.
142. Burrows TD: Cell/Cell and Cell/Matrix Interactions in Human Placental Implantation; PhD thesis University of Cambridge, 1994.
143. Burrows TD, King A, Loke YW: Human trophoblast adhesion to matrix proteins. Inhibition and signal transduction. Hum Reprod 1995;10:2489-2500.
144. Aplin JD: The cell biology of human implantation. Placenta1996;17/5-6: 269-275.
145. Lessey BA: Adhesion molecules and implantation. J Reprod Immunol 2002;55/1-2:101-112.
146. Olivennes F, Ledee-Bataille N, Samama M, Kadoch J, Taupin JL, Dubanchet S, Chaouat G, Frydman R: Assessment of leukemia inhibitory factor levels by uterine flushing at the time of egg retrieval does not adversely affect pregnancy rates with in vitro fertilization. Fertil Steril 2003;79:900-904.
147. Zourbas S, Dubanchet S, Martal J, Chaouat G: Localization of pro-inflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the fetomaternal interface during murine pregnancy. Clin Exp Immunol 2001;1263:519-528.
148. Bilinski P, Roopenian D, Gossler A: Maternal IL-11Rα function is required for normal decidua and fetoplacental development in mice. Genes Dev 1998;12:2234-2243.
149. Robb L, Li R, Hartley L, Nandurkar H, Koetgen F, Begley CG: Infertility in female mice lacking the receptor for interleukin-11 is due to a defective uterine response to implantation. Nat Med 1998;4:303-308.
150. Robb L, Dimitriadis E, Li R, Salamonsen LA: Leukemia inhibitory factor and interleukin-11: Cytokines with key roles in implantation. J Reprod Immunol 2002;57/1-2:129-141.
151. Robertson SA, Seamark RF: Uterine granulocyte macrophage colony stimulating factor in early pregnancy: Cellular origin and potential regulators; in Biologie cellulaire et moléculaire de la relation materno-foetale. Paris, INSERM John Libbey, 1991, pp 113-121.
152. Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG: The role of cytokines in gestation. Crit Rev Immunol 1994;14:239-292.
153. Sjoblom C, Wikland M, Robertson SA: Granulocyte-macrophage colony-stimulating factor (GM-CSF) acts independently of the beta common subunit of the GM-CSF receptor to prevent inner cell mass apoptosis in human embryos. Biol Reprod 2002;67:1817-1823.
154. Roberts JM, Lain KY: Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002;23:359-372.
155. Robillard PY: Interest in preeclampsia for researchers in reproduction. J Reprod Immunol 2002;53/1-2:279-287.
156. Robillard PY, Hulsey TC: Association of pregnancy-induced hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception. Lancet 1996;347:619.
157. Robillard PY, Dekker GA, Hulsey TC: Revisiting the epidemiological standard of preeclampsia: Primigravidity or primipaternity? Eur J Obstet Gynecol Reprod Biol 1999;84:37-41.
158. Redman CW, Sargent IL: The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil 2001;29:518-522.
159. Robertson SA, Mau VJ, Hudson SN, Tremellen KP: Cytokine leukocyte networks and the establishment of pregnancy. Am J Reprod Immunol 1997;37:438-443.
160. Robertson SA, Sharkey DJ: The role of semen in induction of maternal immune tolerance to pregnancy. Semin Immunol 2001;13/4:243-254.
161. Robertson SA, Seamark RF: Granulocyte macrophage colony stimulating factor (GM-CSF) in the murine reproductive tract: Stimulation by seminal factors. Reprod Fertil Dev 1990;2:359-368.
162. Robertson SA, Ingman WV, O'Leary S, Sharkey DJ, Tremellen KP: Transforming growth factor beta - a mediator of immune deviation in seminal plasma. J Reprod Immunol 2002;57/1-2:109-128.
163. Croy BA, Guilbert LJ, Browne MA, Gough NM, Stinchcomb DT, Reed N, Wegmann TG: Characterization of cytokine production by the metrial gland and granulated metrial gland cells. J Reprod Immunol 1991;19:149-166.
164. Saito S, Nishikawa K, Morii T, Enomoto M, Narita N, Motoyoshi K, Ichijo M: Cytokine production by CD16-CD56 bright natural killer cells in the human early pregnancy decidua. Biol Reprod 2002;67:1804-1810.
165. Athanassakis-Vassiliadis I: Lymphokine production by decidual cells in allogeneic and syngeneic murine pregnancy. Cytokine 1993;5:354-361.
166. Athanassakis I, Farmakiotis V, Papadimitriou L: Uterine cytokine production during the menstrual cycle and preimplantation stages in mice. Dev Immunol 1999;7/1:33-42.
167. Jokhi PP, King A, Loke YW: Cytokine production and cytokine receptor expression by cells of the human first trimester placental-uterine interface. Cytokine 1997;9/2:126-137.
168. Fishman P, Falach-Vaknine E, Zigelman R, Bakimer R, Sredni B, Djaldetti M, Shoenfeld Y: Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 1993;91:1834-1837.
169. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993;151:4562-4573.
170. Nishino E, Matsuzaki N, Masuhiro K, Kameda T, Taniguchi T, Takagi T, Saji F, Tanizawa O: Trophoblast-derived interleukin-6 (IL-6) regulates human chorionic gonadotropin release through IL-6 receptor on human trophoblasts. J Clin Endocrinol Metab 1990;71:436-441.
171. Neki R, Matsuzaki N, Yamanaka K, Shimoya K, Okada T, Saji F, Iwashita M, Tanizawa O: The interleukin-6 (IL-6)/IL-6-receptor system induces human chorionic gonadotropin production by activating tyrosine kinase-dependent signal transduction pathway different from pathways triggered by protein kinase activators including gonadotropin releasing hormone. J Clin Endocrinol Metab 1993;77:704-709.
172. Taniguchi T, Matsuzaki N, Jo T, Saji F, Taga T, Hirano T, Kishimoto T, Tanizawa O: Interleukin-1 (IL-1l)-induced IL-6- and IL-6-receptor-mediated release of human chorionic gonadotropin by choriocarcinoma cell lines (Jar and HCCM-5) activates adenosine 3, 5′-monophosphate-independent signal transduction pathway. J Clin Endocrinol Metab 1992;74:1389-1395.
173. Matsuzaki N, Neki R, Sawai K, Shimoya K, Okada T, Sakata M, Saji F, Koishihara Y, Ida N: Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadotropin production by normal human trophoblasts through binding to the IL-6 signal transducer. J Clin Endocrinol Metab 1995;80:2912-2917.
174. Matsuzaki N: Immunological analysis of the mechanism of maternal tolerance of a fetus and the cytokine-mediated regulation of feto-placental functions. Nippon Sanka Fujinka Gakkai Zasshi 1994;46:697-706.
175. Saito S: Cytokine network at the feto-maternal interface. J Reprod Immunol 2000;47/2:87-103.
176. Matsuzaki N, Li Y, Masuhiro K, Jo T, Shimoya K, Taniguchi T, Saji F, Tanizawa O: Trophoblast-derived transforming growth factor-beta 1 suppresses cytokine-induced, but not gonadotropin-releas-ing hormone-induced release of human chorionic gonadotropin by normal human trophoblasts. J Clin Endocrinol Metab 1992;74/1:211-216.
177. Perrier d'Hauterive S: Implantation: The first maternal-embryo crosstalk. J Gynecol Obstet Biol Reprod (Paris) 2004;33/1(Pt 2):S5-S8.
178. Stephanou A, Handwerger S: Interleukin-6 stimulates placental lactogen expression by human trophoblast cells. Endocrinology 1994;135:719-723.
179. Schafer A, Pauli G, Friedmann W, Dudenhausen JW: Human choriogonadotropin (hCG) and placental lactogen (hPL) inhibit interleukin-2 (IL-2) and increase interleukin-1 beta (IL-1 beta), -6 (IL-6) and tumor necrosis factor (TNF-alpha) expression in monocyte cell cultures. J Perinat Med 1992;20/3:233-240.
180. Li Y, Matsuzaki N, Masuhiro K, Kameda T, Taniguchi T, Saji F, Yone K, Tanizawa O: Trophoblast-derived tumor necrosis factor-alpha induces release of human chorionic gonadotropin using interleukin-6 (IL-6) and IL-6-receptor- dependent system in the normal human trophoblasts. J Clin Endocrinol Metab 1992;74/1:184-191.
181. Bischof P: Endocrine, paracrine and autocrine regulation of trophoblastic metalloproteinases. Early Pregnancy 2001;5/1:30-31.
182. Bonhoff A, Gellersen B: Modulation of prolactin secretion in human myometrium by cytokines. Eur J Obstet Gynecol Reprod Biol 1994;54/1:55-62.
183. Kelly PA, Binart N, Lucas B, Bouchard B, Goffin V: Implications of multiple phenotypes observed in prolactin receptor knockout mice. Front Neuroendocrinol 2001;22/2:140-145.
184. Kanaya M, Tanaka S: A role of cytokines produced by allostimulated lymphocytes on maintenance of pregnancy - enhancement of trophoblast proliferation and beta-hCG secretion by cytokines. Nippon Sanka Fujinka Gakkai Zasshi 1994;46:489-496.
185. Cameo P, Bischof P, Calvo JC: Effect of leptin on progesterone, human chorionic gonadotropin, and interleukin-6 secretion by human term trophoblast cells in culture. Biol Reprod 2003;68:472-477.
186. Pellicer A, Albert C, Garrido N, Navarro J, Remohi J, Simon C: The pathophysiology of endometriosis-associated infertility: Follicular environment and embryo quality. J Reprod Fertil Suppl 2000;55:109-119.
187. Lim KJ, Odukoya OA, Ajjan RA, Li TC, Weetman AP, Cooke ID: Profile of cytokine mRNA expression in peri-implantation human endometrium. Mol Hum Reprod 1998;4/1:77-81.
188. Ekerfelt C, Lidstrom C, Matthiesen L, Berg G, Sharma S, Ernerudh J: Spontaneous secretion of interleukin-4, interleukin-10 and interferon-gamma by first trimester decidual mononuclear cells. Am J Reprod Immunol 2002;47/3:159-166.
189. De Moraes-Pinto MI, Vince GS, Flanagan BF, Hart CA, Johnson PM: Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes. Immunology 1997;90/1:87-94.
190. Starkey PM: Expression on cells of early human pregnancy decidua, of the p75, IL-2 and p145, IL-4 receptor proteins. Immunology 1991;73/1:64-70.
191. Saito S, Tsukaguchi N, Hasegawa T, Michimata T, Tsuda H, Narita N: Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am J Reprod Immunol 1999;42/4:240-245.
192. Saito S, Umekage H, Nishikawa K, Morii T, Narita N, Enomoto M, Sakakura S, Harada N, Ichijo M, Morikawa H: Interleukin 4 (IL-4) blocks the IL-2-induced increased in natural killer activity and DNA synthesis of decidual CD16-CD56bright NK cells by inhibiting expression of the IL-2 receptor alpha, beta, and gamma. Cell Immunol 1996;170/1:71-77.
193. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S: Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998;4:1020-1024.
194. Adamson S, Edwin SS, LaMarche S, Mitchell MD: Actions of interleukin-4 on prostaglandin biosynthesis at the chorion-decidual interface. Am J Obstet Gynecol 1993;169:1442-1447.
195. Bry K, Lappalainen U: Interleukin-4 and transforming growth factor-beta 1 modulate the production of interleukin-1 receptor antagonist and of prostaglandin E2 by decidual cells. Am J Obstet Gynecol 1994;170:1194-1198.
196. Dudley DJ, Spencer S, Edwin S, Mitchell MD: Regulation of human decidual cell macrophage inflammatory protein-1 alpha (MIP-1 alpha) production by inflammatory cytokines. Am J Reprod Immunol 1995;34/4:231-235.
197. Grunig G, Antczak DF: Horse trophoblasts produce tumor necrosis factor alpha but not interleukin 2, interleukin 4, or interferon gamma. Biol Reprod 1995;52:531-539.
198. Selick CE, Horowitz GM, Gratch M, Scott RT Jr., Navot D, Hofmann GE: Immunohistochemical localization of transforming growth factor-beta in human implantation sites. J Clin Endocrinol Metab 1994;78:592-596.
199. Clark DA: Maternal immune response to the fetus. EOS Rev Immunol Immunofarmacol 1985;2:114-117.
200. Brooks-Kaiser JC, Hoskin DW: Inhibition of DNA synthesis and IL-2 bioactivity in MLR by pregnancy-associated natural suppressor cells involves the production of a TGF-β1-like molecule and a second distinct inhibitory factor. J Reprod Immunol 1993;25:31-49.
201. Clark DA, Lea RG,Denburg J, Barwatt D,Manual J, Daari N, Underwood J, Magdy M, Mowbray J, Daya S, Chaouat G: Transforming growth factor beta 2 related factor in mammalian pregnancy decidua: Homologies between the mouse and human in successful pregnancy and in recurrent unexplained abortion; in Biologie cellulaire et moléculaire de la relation materno-fetale. Paris, INSERM John Libbey, 1991, pp 171-181.
202. Arck PA, Ferrick DA, Steele-Norwood D, Croitoru K, Clark DA: Murine T cell determination of pregnancy outcome. I. Effects of strain, αβ T cell receptor, γδ Tcell receptor, and γδ T cell subsets. Am J Reprod Immunol 1997;37:492-501.
203. Clark DA,Chaput A,Tutton B: Active suppression of host versus graft reaction in pregnant mice. VII. Spontaneous abortion of CBA X DBA/2 foetuses in the uterus of CBA/J mice correlates with deficient non-T suppressor cell activity. J Immunol 1986;136:1668-1771.
204. Lin HY, Wang HM, Li QL, Liu DL, Zhang X, Liu GY, Qian D, Zhu C: Expression of Smad2 and Smad4, transforming growth factor-beta signal transducers in rat endometrium during the estrous cycle, pre-, and peri-implantation. Anim Reprod Sci 2004;80:303-316.
205. Dunn NR, Vincent SD, Oxburgh L, Robertson EJ, Bikoff EK: Combinatorial activities of Smad2 and Smad3 regulate mesoderm formation and patterning in the mouse embryo. Development 2004;131:1717-1728.
206. Wu MY, Chen HF, Chen SU, Chao KH, Yang YS, Ho HN: Increase in the production of interleukin-10 early after implantation is related to the success of pregnancy. Am J Reprod Immunol 2001;46:386-392.
207. Krishnan L, Guilbert LJ, Wegmann TG, Belosevic M, Mossman TR: Helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorption: Correlation with increased IFN-γ and TNF and reduced IL-10 production by placental cells. J Immunol 1996;156:653-662.
208. Bennett WA, Lagoo-Deenadayalan S, Whitworth NS, Stopple JA, Barber WH, Hale E, Brackin MN, Cowan BD: First-trimester human chorionic villi express both immunoregulatory and inflammatory cytokines: A role for interleukin-10 in regulating the cytokine network of pregnancy. Am J Reprod Immunol 1999;41/1:70-78.
209. Chaouat G, Menu E, De Smedt D, Khrishnan L, Lin Hui, Assal Meliani A, Martal J, Raghupathy R, and Wegmann TG: The emerging role of IL-10 in pregnancy. Am J Reprod Immunol 1995;35:325-329.
210. Chaouat G, Tranchot Diallo J, Volumenie JL, Menu E, Gras G, Delage G, Mogneti G: Immune suppression and Th1/Th2 balance in pregnancy revisited: A (very) personal tribute to Tom Wegmann. Am J Reprod Immunol 1997;37:427-434.
211. White CA, Johansson M, Roberts CT, Ramsay AJ, Robertson SA: Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod 2004;70/1:123-131.
212. Svensson L, Arvola M, Sallstrom MA, Holmdahl R, Mattsson R: The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J Reprod Immunol 2001:51/1:3-7.
213. Fallon PG, Jolin HE, Smith P, Emson CL, Townsend MJ, Fallon R, Smith P, Mc Kenzie AN: IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002;17/1:7-17.
214. Chaouat G, Ledée-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J: Th1/Th2 paradigm in pregnancy: Paradigm lost? Cytokines in pregnancy/early abortion: Re-examining the Th1/Th2 paradigm. Int Arch Allergy Immunol 2004;134:93-119.
215. Arck PC, Merali FS, Manuel JS, Chaouat G, Clark DA: Stress triggered abortion: Inhibition of protective suppression and promotion of tumor necrosis factor alpha (TNF alpha) release as a mechanism triggering resorptions in mice. Am J Reprod Immunol 1995;33/1:74-81.
216. Chaouat G, Lankar D, Kolb JR Clark DA: 2 modèles d'avortements d'origine immunitaire chez la souris de laboratoire: mécanismes abortifs, modalités et mécanismes du traitement par l'immunisation contre un male relie ou non relie suivant les différences antigéniques père mère; in Chaouat G (ed): Colloque INSERM CNRS Immunologie de la relation foeto-maternelle. Paris, INSERM John Libbey, 1987, pp 243-255.
217. Tangri S, Raghupathy R: Expression of cytokines in placenta of mice undergoing immunologically mediated fetal resorption. Biol Reprod 1993;49:840-850.
218. Tangri S, Wegmann TG, Lin H, Raghupathy R: Maternal anti-placental activity in natural, immunologically mediated foetal resorption. J Immunol 1994;152:4903-4910.
219. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997;18:478-482.
220. Hunt JS, Hua Lin C, Miler L: Tumor necrosis factors: Pivotal components of pregnancy? Biol Reprod 1996;54:554-563.
221. Torchinsky A, Shepshelovich J, Orenstein H, Zaslavsky Z, Savion S, Carp H, Fain A, Toder V: TNF-alpha protects embryos exposed to developmental toxicants. Am J Reprod Immunol 2003;49/3:159-168.
222. Ostojic S, Dubanchet S, Mjihdi A, Truyens C, Capron F, Chaouat G: Demonstration of the presence of IL-16, IL-17 and IL-18 at the murine fetomaternal interface during murine pregnancy. Am J Reprod Immunol 2003;49:101-113.
223. Rockwell LC, Pillai S, Olson CE, Koos RD: Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 2002;67:1804-1810.
224. Chaouat G: Placental infiltration of resorbing CBA X DBA/2 embryos. Book of Abstracts. 6th International Congress of Immunology, Toronto, 1986.
225. Gendron R, Baines M: Infiltrating decidual natural killer cells are associated with spontaneous abortion in mice. Cell Immunol 1988;113:261-267.
226. Baines M, Fougerolles R: Modulation of natural killer activity influences resorption rates in CBA X DBA/2 matings. J Reprod Immunol 1988;11:147-153.
227. Baines MG, Gendron RL: Natural and experimental animal models of reproductive failure; in Chaouat G (ed): Immunology of Pregnancy. Boca Raton, CRC Press, 1993, pp 173-203.
228. Kinsky R, Delage G, Rosin N, Thang MN, Hoffman M, Chaouat G: A murine model of NK mediated fetal resorption. Am J Reprod Immunol 1990;23/3:73-78.
229. Anderson DJ, Hill JA: Cell mediated immunity in infertility. Am J Reprod Immunol 1992;17:1:22-31.
230. Hill J: T helper 1 immunity to trophoblast: Evidence for a new immunological mechanism for recurrent abortion in women. Hum Reprod 1995;10:114-120.
231. Hill JA, Polgar K, Anderson DJ: T-helper 1 -type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995;273:1933-1936.
232. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E: Maternal Th1-and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999;196/2:122-130.
233. Croy BA, Ashkar AA, Foster RA, DiSanto JP, Magram J, Carson D, Gendler SJ, Grusby J, Wagner N, Muller W, Guimond MJ: Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy. J Reprod Immunol 1997;35:111-133.
234. Guimond MJ, Luross JA, Wang B, Terhorst C, Danial S, Croy BA: Abscence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice. Biol Reprod 1997;56/1:169-179.
235. Guimond MJ, Wang B, Croy BA: Engraftment of bone marrow from severe combined immunodeficiency (SCID) mice reverses the reproductive deficit in natural killer cell-deficient TgE26 mice. J Exp Med 1998;187:217-223.
236. Miyazaki S, Tanebe K, Sakai M, Michimata T, Tsuda H, Fujimura M, Nakamura M, Kiso Y, Saito S: Interleukin 2 receptor gamma chain (gamma(c)) knockout mice show less regularity in estrous cycle but achieve normal pregnancy without fetal compromise. Am J Reprod Immunol 2002;47/4:222-230.
237. Kitaya K, Yasuda J, Yagi I, Tada Y, Fushiki S, Honjo H: IL-15 expression at human endometrium and decidua. Biol Reprod 2000;63:683-687.
238. Verma S, Hiby SE, Loke YW, King A: Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 2000;62:959-968.
239. Ye W, Zheng LM, Young JD E, Liu CC: The involvement of interleukin-15 in regulating the differentiation of granulated metrial gland cells in mouse pregnant uterus. J Exp Med 1996;184:2405-2410.
240. Allen MP, Nilsen-Hamilton M: Granzymes D, E, F and G are regulated through pregnancy and by IL-2 and IL-15 in granulated metrial gland cells. J Immunol 1998;161:2772-2779.
241. Okada S, Okada H, Sanezumi M, Nakajima T, Yasuda K, Kanzaki H: Expression of interleukin-15 in human endometrium and decidua. Mol Hum Reprod 2000;6/1:75-80.
242. Barber EM, Pollard JW: The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection. J Immunol 2003;171/1:37-46.
243. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL: Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003;198:1201-1212.
244. Voest EE, Kenyen BM, O'Reilly MS, Tsuitt G, D'Amato RJ, Folkman J: Inhibition of angiogenesis by interleukin-12. J Natl Cancer Inst 1995;87:581-586.
245. Sacks GP, Redman CW, Sargent IL: Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: An intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol 2003;131:490-497.
246. Zenclussen AC, Fest S, Busse P, Joachim R, Klapp BF, Arck PC: Questioning the Th1/Th2 paradigm in reproduction: Peripheral levels of IL-12 are down-regulated in miscarriage patients. Am J Reprod Immunol 2002;48/4:245-251.
247. Muranaka J, Tsuji Y, Hasegawa A, Ida ANakata Y, Kanazawa R, Koyama K: Interleukin-18 as an important new cytokine in pregnancy (abstract). 7th International Congress of Reproductive Immunology, 27-30 Oct., New Delhi. Am J Reprod Immunol 1998;40:278.
248. Hayakawa S, Fujikawa T, Fukuoka H, Chisima F, Karasaki-Suzuki M, Ohkoshi E, Ohi H, Kiyoshi Fujii T, Tochigi M, Satoh K, Shimizu T, Nishinarita S, Nemoto N, Sakurai I: Murine foetal resorbtion and experimental pre-eclampsia are induced by both excessive Th1 and Th2 activation. J Reprod Immunol 2000;47/2:121-138.
249. Zenclussen AC, Joachim R, Hagen E, Peiser C, Klapp BF, Arck PC: Heme oxygenase is downregulated in stress-triggered and interleukin-12-mediated murine abortion. Scand J Immunol 2002;55:560-569.
250. Zenclussen AC, Fest S, Joachim R, Busse P, Klapp BF, Arck PC: Introducing a novel mouse model for preeclampsia (abstract O 36). Am J Reprod Immunol 2002;47:353.
251. Croy BA, Ashkar AA, Minhas K, Greenwood JD: Can murine uterine natural killer cells give insights into the pathogenesis of pre eclampsia? J Soc Gynecol Investig 2001;7/1:12-20.
252. Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, Licence D, Bowen JM, Gardner L, King A, Loke YW, Smith SK: Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 2001;86:1823-1834.
253. Ashkar AA, Di Santo JP, Croy BA: Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000;192/2:259-270.
254. Zhang JH, He H, Borzychowski AM, Takeda K, Akria S, Croy BA: Analysis of cytokine regulators inducing interferon production by mouse uterine natural killer cells. Biol Reprod 2003;69:404-411.
255. Ledée-Bataille N, Dubanchet S, Coulomb L'hermine A, Durand Gasselin I, Frydman R, Chaouat G: A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation fail-ure after in vitro fertilization. Fertil Steril 2004;81/1:59-65.
256. Devergne O, Coulomb-l'Hermine A, Capel F, Moussa M, Capron F: Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: Involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol 2001;159:1763-1776.
257. Hayakawa S, Nagai N, Kanaeda T, et al: Interleukin-12 augments cytolytic activity of peripheral and decidual lymphocytes against choriocarcinoma cell lines and primary culture human placental trophoblasts. Am J Reprod Immunol 1999;41:320-329.
258. Yoshino O, Osuga Y, Koga K, et al: Evidence for the expression of interleukin (IL)-18, IL-18 receptor and IL-18 binding protein in the human endometrium. Mol Hum Reprod 2001;7:649-654.
259. Ledée-Bataille N. Bonnet-Chea K, Hosny G, Dubanchet S, Frydman R, Chaouat G: The role of the endometrial tripod interleukin-18, -15, -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril, in press.
260. Croy BA, Esadeg S, Chantakru S, van den Heuvel M, Paffaro VA, He H, Black GP, Ashkar AA, Kiso Y, Zhang J: Update on pathways regulating the activation of uterine natural killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J Reprod Immunol 2003;59/2:175-191.
261. Croy BA, He H, Esadeg S, Wei Q, McCartney D, Zhang J, Borzychowski A, Ashkar AA, Black GP, Evans SS, Chantakru S, Van Den Heuvel M, Paffaro VA Jr, Yamada AT: Uterine natural killer cells: Insights into their cellular and molecular biology from mouse modelling. Reproduction 2003126/2:149-160.
262. Zygmunt M, Hahn D, Kiesenbauer N, Münstedt K, Lang U: Invasion of cytotrophoblastic (JEG-3) cells is up-regulated by interleukin-15 in vitro. Am J Reprod Immunol 1998;40:326-331.
263. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K, Rao CV, Lang U, Preissner KT: Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 2002;87:5290-5296.
264. Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;2281:1191-1193.
265. Xu C, Mao D, Holers M, Palanca B, Cheng AM, Molina H: A critical role for complement regulator crry in fetomaternal tolerance. Science 2000;287:498-499.
266. Das C, Basak S: Expression and regulation of integrin receptors in human trophoblast cells: Role of estradiol and cytokines. Indian J Exp Biol 2003;41:748-755.
267. Gonzalez RR, Rueda BR, Ramos MP, Littell RD, Glasser S, Leavis PC: Leptin-induced increase in leukemia inhibitory factor and its receptor by human endometrium is partially mediated by interleukin 1 receptor signaling. Endocrinology 2004;145:3850-3857.
268. Deb K, Chaturvedi MM, Jaiswal YK: A 'minimum dose' of lipopolysaccharide required for implantation failure: Assessment of its effect on the maternal reproductive organs and interleukin-1alpha expression in the mouse. Reproduction 2004;128/1:87-97.
269. Check JH, Nowroozi K, Choe J, Dietterich C: Influence of endometrial thickness and echo patterns on pregnancy rates during in vitro fertilization. Fertil Steril 1991;56:1173-1175.
270. Sher G, Herbert C, Maassarani G, Jacobs MH: Assessment of the late proliferative phase endometrium by ultrasonography in patients undergoing in-vitro fertilization and embryo transfer (IVF/ET). Hum Reprod 1991;6:232-237.
271. Dickey RP, Olar TT, Curole DN, Taylor SN, Rye PH: Endometrial pattern and thickness associated with pregnancy outcome after assisted reproduction technologies. Hum Reprod 1992;7:418-421.
272. Yuval Y, Lipitz S, Dor J, Achiron R: The relationships between endometrial thickness, and blood flow and pregnancy rates in in-vitro fertilization. Hum Reprod 1999;14:1067-1071.
273. Oliveira JB, Baruffi RL, Mauri AL, Petersen CG, Borges MC, Franco JG Jr: Endometrial ultrasonography as a predictor of pregnancy in an in-vitro fertilization programme after ovarian stimulation and gonadotrophin-releasing hormone and gonadotrophins. Hum Reprod 1997;12:2515-2518.
274. Yuval Y, Lipitz S, Dor J, Achiron R: The relationships between endometrial thickness, and blood flow and pregnancy rates in in-vitro fertilization. Hum Reprod 1999;14:1067-1071.
275. Steer CV, Tan SL, Mason BA, Campbell S: Midluteal-phase vaginal color Doppler assessment of uterine artery impedance in a subfertile population. Fertil Steril 1994;61:53-58.
276. Chien LW, Tzeng CR, Chang SR, Chen AC: The correlation of the embryo implantation rate with uterine arterial impedance in in vitro fertilization and embryo transfer. Early Pregnancy 1995;1:27-32.
277. Salle B, Bied-Damon V, Benchaib M, Desperes S, Gaucherand P, Rudigoz RC: Preliminary report of an ultrasonography and colour Doppler uterine score to predict uterine receptivity in an in-vitro fertilization programme. Hum Reprod 1998;13:1669-1673.
278. Krussel JS, Huang HY, Hirchenhain J, Bielfeld P, Cupisti S, Jeremias L, Polan ML: Is there a place for biochemical embryonic preimplantational screening? J Reprod Fertil Suppl 2000;55:147-159.